- Home
- ZSPC vs HUMAW Comparison
ZSPC vs HUMAW Comparison
Compare ZSPC & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZSPC
- HUMAW
- Stock Information
- Founded
- ZSPC 2007
- HUMAW 2004
- Country
- ZSPC United States
- HUMAW United States
- Employees
- ZSPC N/A
- HUMAW 220
- Industry
- ZSPC
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- ZSPC
- HUMAW Health Care
- Exchange
- ZSPC NYSE
- HUMAW Nasdaq
- Market Cap
- ZSPC N/A
- HUMAW N/A
- IPO Year
- ZSPC 2024
- HUMAW N/A
- Fundamental
- Price
- ZSPC $3.00
- HUMAW N/A
- Analyst Decision
- ZSPC Strong Buy
- HUMAW
- Analyst Count
- ZSPC 3
- HUMAW 0
- Target Price
- ZSPC $13.33
- HUMAW N/A
- AVG Volume (30 Days)
- ZSPC 46.6K
- HUMAW 14.2K
- Earning Date
- ZSPC 08-15-2025
- HUMAW 03-21-2025
- Dividend Yield
- ZSPC N/A
- HUMAW N/A
- EPS Growth
- ZSPC N/A
- HUMAW N/A
- EPS
- ZSPC 1.05
- HUMAW N/A
- Revenue
- ZSPC $37,016,000.00
- HUMAW N/A
- Revenue This Year
- ZSPC $3.32
- HUMAW N/A
- Revenue Next Year
- ZSPC $45.99
- HUMAW N/A
- P/E Ratio
- ZSPC $2.91
- HUMAW N/A
- Revenue Growth
- ZSPC N/A
- HUMAW N/A
- 52 Week Low
- ZSPC $2.76
- HUMAW $1.18
- 52 Week High
- ZSPC $32.69
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- ZSPC N/A
- HUMAW N/A
- Support Level
- ZSPC N/A
- HUMAW N/A
- Resistance Level
- ZSPC N/A
- HUMAW N/A
- Average True Range (ATR)
- ZSPC 0.00
- HUMAW 0.00
- MACD
- ZSPC 0.00
- HUMAW 0.00
- Stochastic Oscillator
- ZSPC 0.00
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.